[HTML][HTML] Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients
F Ye, H Li, X Chen, Y Wang, W Lin, H Chen, S Huang… - Medicine, 2022 - journals.lww.com
Objective to evaluate the clinical efficacy and safety of sacubitril valsartan in the treatment of
heart failure (HF) with midrange ejection fraction after acute myocardial infarction (AMI) in …
heart failure (HF) with midrange ejection fraction after acute myocardial infarction (AMI) in …
Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients
F Ye, H Li, X Chen, Y Wang, W Lin, H Chen… - Medicine, 2022 - ingentaconnect.com
Objective to evaluate the clinical efficacy and safety of sacubitril valsartan in the treatment of
heart failure (HF) with midrange ejection fraction after acute myocardial infarction (AMI) in …
heart failure (HF) with midrange ejection fraction after acute myocardial infarction (AMI) in …
[HTML][HTML] Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients
F Ye, H Li, X Chen, Y Wang, W Lin, H Chen, S Huang… - Medicine, 2022 - journals.lww.com
Objective to evaluate the clinical efficacy and safety of sacubitril valsartan in the treatment of
heart failure (HF) with midrange ejection fraction after acute myocardial infarction (AMI) in …
heart failure (HF) with midrange ejection fraction after acute myocardial infarction (AMI) in …
Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients.
F Ye, H Li, X Chen, Y Wang, W Lin, H Chen, S Huang… - Medicine, 2022 - europepmc.org
Objective to evaluate the clinical efficacy and safety of sacubitril valsartan in the treatment of
heart failure (HF) with midrange ejection fraction after acute myocardial infarction (AMI) in …
heart failure (HF) with midrange ejection fraction after acute myocardial infarction (AMI) in …
Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients
F Ye, H Li, X Chen, Y Wang, W Lin, H Chen… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective to evaluate the clinical efficacy and safety of sacubitril valsartan in the treatment of
heart failure (HF) with midrange ejection fraction after acute myocardial infarction (AMI) in …
heart failure (HF) with midrange ejection fraction after acute myocardial infarction (AMI) in …
[HTML][HTML] Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients
F Ye, H Li, X Chen, Y Wang, W Lin, H Chen, S Huang… - Medicine, 2022 - ncbi.nlm.nih.gov
Objective to evaluate the clinical efficacy and safety of sacubitril valsartan in the treatment of
heart failure (HF) with midrange ejection fraction after acute myocardial infarction (AMI) in …
heart failure (HF) with midrange ejection fraction after acute myocardial infarction (AMI) in …